Clinical trial
Anti-HIV Medications for People Recently Infected With HIV
NCT00106171 · Johns Hopkins Bloomberg School of Public Health, Other · Completed
Key facts
| NCT number | NCT00106171 |
|---|---|
| Title | Anti-HIV Medications for People Recently Infected With HIV |
| Official title | A Randomized Trial of HAART in Acute/Early HIV Infection |
| Lead sponsor | Johns Hopkins Bloomberg School of Public Health, Other |
| Collaborators | National Institute of Allergy and Infectious Diseases (NIAID) NIH |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | Highly active antiretroviral therapy (HAART) |
| Enrollment | 113 |
| Start date | May 1, 2005 |
| Primary completion | May 1, 2012 |
| Completion | May 1, 2012 |
| First posted | Mar 22, 2005 |
| Last update posted | Sep 13, 2023 |
| Countries | Canada, United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: